<SEC-DOCUMENT>0001354457-25-001190.txt : 20251128
<SEC-HEADER>0001354457-25-001190.hdr.sgml : 20251128
<ACCEPTANCE-DATETIME>20251128130017
ACCESSION NUMBER:		0001354457-25-001190
CONFORMED SUBMISSION TYPE:	25-NSE/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251128
DATE AS OF CHANGE:		20251128
EFFECTIVENESS DATE:		20251128

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIXTE BIOTECHNOLOGY HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001335105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				202903526
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-248588
		FILM NUMBER:		251534320

	BUSINESS ADDRESS:	
		STREET 1:		433 PLAZA REAL
		STREET 2:		SUITE 275
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33432
		BUSINESS PHONE:		310 203 2902

	MAIL ADDRESS:	
		STREET 1:		433 PLAZA REAL
		STREET 2:		SUITE 275
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33432

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SRKP 7 INC
		DATE OF NAME CHANGE:	20050803

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasdaq Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		ORGANIZATION NAME:           	
		EIN:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE/A

	BUSINESS ADDRESS:	
		STREET 1:		One Liberty Plaza
		CITY:			New York
		STATE:			NY
		ZIP:			10006
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		Office of General Counsel
		STREET 2:		805 King Farm Blvd.
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	The Nasdaq Stock Market LLC
		DATE OF NAME CHANGE:	20060224
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001335105</cik>
        <entityName>LIXTE BIOTECHNOLOGY HOLDINGS, INC.</entityName>
        <fileNumber>333-248588</fileNumber>
        <address>
            <street1>248 Route 25A</street1>
            <street2>No. 2</street2>
            <city>East Setauket</city>
            <stateOrCountryCode>NY</stateOrCountryCode>
            <stateOrCountry>NEW YORK</stateOrCountry>
            <zipCode>11733</zipCode>
        </address>
        <telephoneNumber>6468943135</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Warrants</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(2)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>AVP</signatureTitle>
        <signatureDate>2025-11-28</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>lixtw-form25.txt
<TEXT>
Lixtw-form25






</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
